Man Group PLC Applied Genetic Technologies Corp Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.28 - $7.15 $295,602 - $926,997	-129,650 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.85 - $7.35 $997,604 - $1.9 Million	-259,118 Reduced 66.65%	129,650 $946,000
Q2 2018 Aug 14, 2018	SELL	$3.7 - $5.65 $321,248 - $490,555	-86,824 Reduced 18.26%	388,768 $1.44 Million
Q1 2018 May 15, 2018	BUY	$3.65 - $5.2 $1.74 Million - $2.47 Million	475,592 New	475,592 $1.83 Million

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.